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CASE REPORT
A case report of inhalation anthrax 
acquired naturally
Zohreh Azarkar1 and Majid Zare Bidaki2*
Abstract 
Background: Anthrax is a zoonotic occupational disease caused by Bacillus anthracis, a rod-shaped immobile aerobic 
gram-positive bacteria with spore. Anthrax occurs in humans randomly and with low frequency. Most cases of anthrax 
are acquired through contact with infected animals or contaminated animal products. This old disease became 
particularly important since 2001 that the biological spores were exploited in America. Depending on the transmis-
sion method of the disease, clinical manifestations occur in three classes: Cutaneous, respiratory, and gastrointestinal 
anthrax. The respiratory form is considered as the most fatal and a rare form of anthrax intending to show compli-
cated and unusual manifestations.
Case presentation: In this case report a rare case of inhalation anthrax acquired naturally in southeast of Iran is 
presented. A blind 65-year-old man, living in a rural area, was admitted with respiratory infection, fever, dyspnea, loss 
of appetite, and myalgia. The patient was treated with outpatient antibiotics a week ago. After admission, the patient 
was again treated for pneumonia, but there was no improvement despite treatment and the patient was suffering 
from septicemia symptoms. Radiographic images showed wide mediastinum. Bacillus anthracis was isolated from 
blood and sputum culture and the results were confirmed by colony morphology, biochemical reactions and PCR. 
The treatment was changed to ciprofloxacin, clindamycin, and penicillin. On the second day of anthrax treatment, the 
patient was complicated with jaundice, elevation of liver enzymes, and a significant drop in hemoglobin, hematocrit, 
and platelet despite lack of obvious bleeding and was complicated with respiratory distress and sepsis and died a 
week after treatment.
Conclusions: We could discover no specific exposure associated with anthrax infection for this patient. However, due 
to being located in an endemic and enzootic area, it is proposed that the exposure occurred through contact with 
infected airborne dust or an unknown contaminated item. Despite many advances in preventing anthrax, still some 
rare cases of respiratory and complicated anthrax are emerging. With regard to the threat of bioterrorism, medical 
staff’s sensitivity to the clinical syndrome, methods of prophylaxis and treatment of anthrax must be raised. Fast diag-
nosis and successful treatment the lethal cases of this infection are of utmost important.
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Background
Anthrax is a zoonotic occupational disease caused by 
Bacillus anthracis, a rod-shaped immobile aerobic gram-
positive spore former bacterium. The spores can survive 
in the soil for years and primarily infect vegetarians. 
Anthrax occurs in humans randomly and with low fre-
quency. No known cases of direct transmission of its 
causative agent, B. anthracis, from human to human has 
been reported, but the infection is acquired through con-
tact with infected animals or contaminated animal prod-
ucts [1, 2]. Due to the frequency of infection in workers 
exposed to contaminated animal products, in nineteenth 




*Correspondence:  m.zare@live.co.uk 
2 Hepatitis Research Center, Medical Microbiology Department, 
Paramedical Faculty, Birjand University of Medical Sciences, Ghafari 
Avenue, Birjand, South Khorasan, Iran
Full list of author information is available at the end of the article
Page 2 of 5Azarkar and Zare Bidaki  BMC Res Notes  (2016) 9:141 
This old disease became particularly important since 
2001 that the biological spores were exploited in Amer-
ica. Depending on the transmission method of the dis-
ease, clinical manifestations occur in three classes: 
cutaneous, respiratory, and gastrointestinal anthrax, 
95 % of which include the cutaneous form [1–3] and the 
respiratory form is considered as the most fatal form 
of anthrax reported which can lead to fatal septicemia. 
However, some other unusual manifestations have also 
been reported [2, 4]. In this report a rare case of inha-
lation anthrax acquired naturally is presented. This may 
underline the challenges of working on anthrax cases 
when no exact source of the infection exists.
Case presentation
The patient was a 65-year-old blind man, living in coun-
tryside of Birjand, the center of South Khorasan province 
located in southeast of Iran. The case-patient mainly lived 
alone in the past 3 months due to his wife’s death. He had 
a history of keeping animals including some sheep and 
goats at home, but his animals were not infected. He had 
a long history of COPD. But his symptoms had started a 
week ago. The symptoms had not improved despite anti-
biotic treatment and therefore, the patient was referred 
to us at the medical center of the province. He character-
ized with mild fever, dyspnea, pussy non-bloody sputum, 
anorexia, and myalgia. In primary examination, he had a 
blood pressure of 120/80  mmHg, respiratory rate of 24 
per minute, pulse rate of 90 beats per minute, and a tem-
perature of 37.6  °C. In physical examination, he had no 
skin rash, ulcer, and necrosis in his face and extremities, 
and also no symptoms of icterus were observed. Lung 
auscultation revealed a slightly hoarse voice. The patient 
had no signs of meningeal irritation and chest x-ray was 
normal.
Initial tests of the patient were as follows: White 
blood cell =  7.3 ×  103/µL, Neutrophils =  85 %, Hemo-
globin  =  13.2  g/dl, Hematocrit  =  42.2  %, Plate-
let  =  137  ×  103/µL, ESR  =  19, CRP  =  2+, Urine 
analysis = normal.
By physical examination, patient was diagnosed as 
exacerbation of COPD or pneumonia and received intra-
venous ceftriaxone and azithromycin. Despite 3 days of 
treatment, his symptoms did not change and the patient 
became slightly disoriented. Because of the intermittent 
sleepiness, lack of signs of meningeal irritation and lack 
of his next of kin consent, the patient did not undergo 
lumbar puncture, but blood samples were sent to the lab-
oratory for examination.
The first blood sampling was taken on the 1st day 
of admission but the results were reported to the 
ward on the 3rd day. According to laboratory reports, 
microscopic blood samples revealed presence of 
gram-positive streptobacilli. Blood culture on blood agar 
showed growth of creamy coarse grayish texture with 
irregular borders colonies without hemolysis looking 
like a jellyfish. In the next stage, by conducting a num-
ber of microbial enzymatic and metabolic tests, includ-
ing motility, gelatin hydrolysis, bacterial sensitivity to 
penicillin, string of pearls test, sugars fermentation, B. 
anthracis was strongly suggested. All these routine labo-
ratory procedures took 48 h.
On the 3rd day of hospitalization, the chest x-ray of 
the patient was repeated, which showed closed right side 
angles, wide mediastinum, and opacities in lower region 
of the lung.
With regard to blood culture results and x-rays of the 
patient, the antibiotic was changed to ciprofloxacin, clin-
damycin, and penicillin. Moreover, the patient’s blood 
and lung secretion samples were sent to the National Ref-
erence Laboratory to repeat the culture and subsequently 
to do PCR.
On the 2nd day of anthrax treatment, the patient was 
complicated with jaundice, elevation of liver enzymes, 
and a significant drop in hemoglobin, hematocrit, and 
platelet despite lack of obvious bleeding and this was 
complicated with respiratory distress and sepsis. The 
patient was finally died a week after treatment. Autopsy 
was not performed because of discontentment of 
patient’s family. The organism isolated repeatedly from 
the blood and from the lung secretion, and the results of 
PCR confirmed respiratory anthrax and the subsequent 
sepsis.
Reporting this critical finding to public health depart-
ment, a group of health care workers were assigned to 
mission visiting the case-patient’s rural house and car-
rying out a disinfect process there. During the visit, they 
found an unprocessed sheepskin used as flooring. How-
ever, bacteriological analysis of samples taken from the 
sheepskin did not reveal any trace of B. anthracis. Envi-
ronmental sampling was not conducted for B. anthracis.
Discussion
Anthrax is a zoonotic disease. Epidemiologic studies 
and case reports have shown that most cases of anthrax 
infection occurs in people living in rural areas or in 
occupations related to animal products [5–7]. The most 
common form of anthrax infection in humans is the 
cutaneous form that is diagnosed by a topical skin lesion 
with central scar and marked non-pitting edema.
In contrast, the prevalence of respiratory anthrax infec-
tion is very low; it usually begins with acute signs and 
respiratory symptoms such as dyspnea, hypoxia, and 
hypotension occurs 1–3  days after the onset of the dis-
ease that results in death within a short time. Sometimes 
patients are discovered with bleeding mediastinitis in 
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autopsies [1, 2]. In cases where these organisms enter the 
bloodstream and septicemia occurs, the number of bac-
teria per cubic centimeter of blood can ultimately reach 
more than 108 before the patient’s death.
In the early 1900s, the human cases of respiratory 
anthrax in the United States occurred mainly in those 
who had contact with textiles and leather industry and 
was named as Wool sorter disease. In the late twenti-
eth century, with the increase in health level and pro-
tection of animal products, the disease prevalence was 
reduced, but the death cases were still very high (>85 %). 
In 1979, in the Sverdlovsk event in an industrial zone 
in the former Soviet Union, an epidemic of respiratory 
anthrax occurred due to the recklessness in the mili-
tary industry. In 2001, ten cases of deliberate infection 
of respiratory anthrax were confirmed that was due to a 
bioterrorist attack on the United States, in which indi-
viduals were targeted with packets of B. anthracis spores 
[8, 10]. Whereas, only 18 cases of respiratory anthrax 
was reported in the US prior to that, the latest of which 
happened in 1976 [8, 9]. Moreover, a systematic review 
conducted in 2006 showed that the total number of inha-
lation anthrax cases reported in any languages between 
years 1900 and 2005 was 82 [10]. This apparently reveals 
the rare incident of this disease in general. Therefore, 
reports of anthrax is currently of particular importance in 
the whole world. Most cases of anthrax reported in Iran 
include cutaneous, gastrointestinal and meningitis types 
[5–7]. Based on the results of medical databases, this was 
the first respiratory anthrax over the last 30 years in Iran.
Respiratory anthrax starts with feeling unwell, myalgia, 
fatigue, fever, nonproductive cough and then more severe 
respiratory distress and cyanosis occurs and the patient 
usually dies within 1–2 days. In this case report, the onset 
of symptoms was respiratory and gradually progressed. 
The patient was complicated with jaundice, elevated liver 
enzymes, and respiratory distress after 5 days. Regarding 
the mediastinal edema in patients suffering from respira-
tory anthrax, which is due to bacillus anthrax secreting 
edema factor, chest x-ray is considered a sensitive meas-
urement in the diagnosis of respiratory anthrax. Respira-
tory manifestations occur in several forms in patients, 
including mediastinal widening, involvements around 
trachea, hilar infiltration, pleurisies, and parenchymal 
infiltration [1, 11].
In this case, the initial chest x-ray was normal, but 
after a few days infiltration, pulmonary edema, pleuri-
sies, and mediastinal widening was observed, despite res-
piratory symptoms did not deteriorate. Number of white 
blood cells is normal or slightly increased in respiratory 
anthrax. Particularly, increased neutrophils can help 
the diagnosis of the disease primarily [11]. However, no 
increase in the number of leukocytes, especially neutro-
phils were observed in the reported patient.
In animals with respiratory anthrax infection, bactere-
mia is reported in the early phase of the disease before 
fulminant symptoms. But blood culture rapidly becomes 
negative after antibiotic treatment. Administration of 
antibiotics before blood culture results in negative blood 
culture, which is the most definitive method of diagno-
sis [9]. Nevertheless, blood and sputum cultures of the 
reported case were still positive after 3 days of antibiotic 
therapy.
Natural acquisition of anthrax’s means transmission 
of disease through contact with infected animals or ani-
mal products to human. The last known case of anthrax 
respiratory disease acquired normally was in America 
in 1976 [12]. Thereafter, the involvement of respiratory 
anthrax has been usually due to bioterrorism or after sep-
sis caused by cutaneous wounds. But in our case, natu-
ral acquisition of respiratory anthrax occurred without 
injury or risk of bioterrorist attack. The source of the 
disease was not detected in the medical history of the 
patient, but it seemed that the patient acquired anthrax 
due to contact with animals and their products. “As a 
villager blind, he used to touch and smell anything for 
finding his wanted items around”, Said our patient’s son 
to health care workers. The above sentence may show a 
strong clue proposing the way that the case-patient was 
infected. It seems that he acquired anthrax due to adja-
cent contact with animals’ products, especially with 
wool. Soil might be the other alternative source of this 
contamination. A previous research conducted on deter-
mination of anthrax foci throughout Iran, southeast of 
the country (Khorasan region) was demonstrated as one 
of the endemic regions [13]. Intensive rain or drought 
leads the spores to bud and reproduce B. anthracis that 
cause the bacteria to multiply enough to cause infection 
[1, 9]. Considering the prolonged droughts in the border 
areas of East Iran, drought is perhaps one of the reasons 
of occurrence of this disease.
The survival of patients with respiratory anthrax is 
reported 60 % in some studies and higher in some other. 
This patient was treated with a combination of antibiot-
ics, effective against B. anthracis (Ciprofloxacin 400  mg 
q12 h IV, Clindamycin 600 mg q8 h IV, and Penicillin 2 
MU q2 h IV).
Resistance to Penicillin has increased and the drug 
is not used in this occasion in many parts of the world. 
However, antimicrobial susceptibility testing showed 
that the isolate was totally sensitive to Penicillin. More-
over, Penicillin is the drug of choice to treat coutanous 
anthrax in this region and we have had previous success-
ful experiences.
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Bacillus Anthracis generates cephalosporinase that 
can inhibit the activity of cephalosporins, such as ceftri-
axone. Therefore, cephalosporin should not be used in 
the treatment of this disease. Early detection and treat-
ment, proper antibiotics, differences in the pathogenesis 
of anthrax cases caused by bioterrorism, host sensitivity 
or a combination of these factors contribute to patient 
survival [1, 9]. Administration of anti-anthrax antiserum 
has shown to improve some human cases of anthrax. In 
anthrax generated in animal models, the best treatment 
for anthrax infections is appropriate antibiotic and anti-
serum. Also, in some cases, a combination of human 
immunoglobulin and antibiotic administration were 
effective. [10, 12].
Further studies are needed to detected adjuvant thera-
pies, such as human immunoglobulin and anti-toxin, cor-
ticosteroids, and other toxin inhibitors in the treatment 
of anthrax.
Respiratory anthrax should be considered in dif-
ferential diagnosis of patients with severe pulmonary 
involvement and in endemic areas due to its mor-
tality and similarity of its symptoms to lower and 
upper respiratory infections and other respiratory 
involvements.
Comments and conclusions
We could discover no specific exposure associated with 
anthrax infection for this patient. However, it is pro-
posed that the exposure occurred through contact with 
infected airborne dust or an unknown contaminated 
item. Immunodeficiency and chronic pulmonary disease 
can increase the susceptibility to inhalation anthrax [14]. 
This old patient had a long history of COPD, possibly this 
increased his risk.
We advise that inhalation anthrax should be consid-
ered in patients with severe pulmonary involvement, 
especially in endemic regions due to its high rate of mor-
tality and also the similarity of its symptoms to lower 
and upper respiratory infections and other respiratory 
involvements.
In spite of enhancement in preventing anthrax, still 
some rare cases of respiratory and complicated anthrax 
are emerging. These cases are found much more in 
endemic end enzootic regions of the world. With regard 
to the threat of bioterrorism, medical staff’s sensitivity 
to the clinical syndrome, methods of prophylaxis and 
treatment of anthrax must be raised. Fast diagnosis and 
successful treatment of inhalation and sepsis cases of 
anthrax are of utmost important.
This case study was limited by lack of soil and environ-
mental sampling. The other limitation was lack of deter-
mination of MIC for the prescribed antibiotics.
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